X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (4286) 4286
humans (4141) 4141
life sciences & biomedicine (3993) 3993
female (2100) 2100
oncology (1993) 1993
b7-h1 antigen - metabolism (1798) 1798
male (1658) 1658
animals (1534) 1534
immunotherapy (1486) 1486
middle aged (1356) 1356
aged (1192) 1192
b7-h1 antigen - antagonists & inhibitors (1137) 1137
b7-h1 antigen - immunology (1136) 1136
immunology (1107) 1107
mice (1054) 1054
adult (1036) 1036
pd-l1 (1028) 1028
b7-h1 antigen - genetics (1007) 1007
apoptosis (943) 943
cancer (938) 938
tumors (872) 872
pd-l1 protein (829) 829
prognosis (811) 811
immunohistochemistry (782) 782
b7-h1 antigen (775) 775
lymphocytes (740) 740
programmed cell death 1 receptor - antagonists & inhibitors (737) 737
ligands (679) 679
cell line, tumor (642) 642
t cells (619) 619
aged, 80 and over (615) 615
programmed cell death 1 receptor - immunology (578) 578
programmed cell death 1 receptor - metabolism (576) 576
pd-1 (526) 526
lymphocytes t (522) 522
pd-1 protein (519) 519
immune checkpoint (516) 516
gene expression (511) 511
antibodies, monoclonal - therapeutic use (502) 502
immunotherapy - methods (492) 492
lung cancer (486) 486
mice, inbred c57bl (472) 472
t-lymphocytes - immunology (471) 471
abridged index medicus (462) 462
care and treatment (459) 459
research (459) 459
metastasis (450) 450
cell biology (433) 433
patients (433) 433
analysis (428) 428
treatment outcome (422) 422
cd8-positive t-lymphocytes - immunology (418) 418
cell death (414) 414
melanoma (407) 407
lung neoplasms - pathology (400) 400
pathology (395) 395
antineoplastic agents - therapeutic use (392) 392
chemotherapy (392) 392
cancer therapies (384) 384
neoplasms - immunology (375) 375
mutation (372) 372
lung neoplasms - drug therapy (363) 363
immune system (362) 362
signal transduction (360) 360
b7-h1 antigen - biosynthesis (357) 357
flow cytometry (357) 357
gene expression regulation, neoplastic (356) 356
b7-h1 (353) 353
health aspects (352) 352
biomarkers, tumor - metabolism (350) 350
biomarkers (347) 347
medical prognosis (346) 346
antigens (343) 343
neoplasm staging (340) 340
lymphocytes, tumor-infiltrating - immunology (331) 331
antineoplastic agents, immunological - therapeutic use (330) 330
immune response (311) 311
programmed cell death 1 receptor (309) 309
carcinoma, non-small-cell lung - drug therapy (303) 303
retrospective studies (299) 299
b7-h1 antigen - analysis (298) 298
medicine, research & experimental (296) 296
research & experimental medicine (295) 295
proteins (293) 293
science & technology - other topics (289) 289
metastases (286) 286
lung neoplasms - metabolism (285) 285
ctla-4 antigen - antagonists & inhibitors (282) 282
clinical trials (273) 273
multidisciplinary sciences (272) 272
genetic aspects (270) 270
hematology (269) 269
cell proliferation (268) 268
programmed cell death 1 receptor - genetics (267) 267
research article (266) 266
carcinoma, non-small-cell lung - pathology (264) 264
young adult (263) 263
kaplan-meier estimate (262) 262
mice, inbred balb c (261) 261
lung neoplasms - immunology (258) 258
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4809) 4809
Chinese (198) 198
French (33) 33
Japanese (32) 32
German (12) 12
Czech (7) 7
Russian (6) 6
Polish (4) 4
Portuguese (3) 3
Italian (2) 2
Spanish (2) 2
Hungarian (1) 1
Korean (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of thoracic oncology, ISSN 1556-0864, 06/2015, Volume 10, Issue 6, pp. 910 - 923
Epidermal growth factor receptor (EGFR) mutation status was reported to be associated with programmed death-ligand 1 (PD-L1) expression. However, the molecular... 
PD-L1 | NSCLC | PD-1 | EGFR | Tyrosine kinase inhibitors | Respiratory System | Oncology | Life Sciences & Biomedicine | Science & Technology | Tumor Escape - drug effects | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Sequence Deletion | Up-Regulation | Exons | Humans | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Molecular Targeted Therapy | Receptor, Epidermal Growth Factor - metabolism | T-Lymphocytes - pathology | Lung Neoplasms - genetics | Receptor, Epidermal Growth Factor - immunology | Lung Neoplasms - enzymology | Signal Transduction | Carcinoma, Non-Small-Cell Lung - genetics | Programmed Cell Death 1 Receptor - metabolism | B7-H1 Antigen - genetics | B7-H1 Antigen - immunology | Carcinoma, Non-Small-Cell Lung - immunology | B7-H1 Antigen - metabolism | Lung Neoplasms - immunology | Apoptosis - immunology | B7-H1 Antigen - antagonists & inhibitors | Interferon-gamma - immunology | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | T-Lymphocytes - immunology | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Programmed Cell Death 1 Receptor - immunology | Programmed Cell Death 1 Receptor - genetics | Interferon-gamma - biosynthesis | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 10/2015, Volume 373, Issue 17, pp. 1627 - 1639
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 02/2016, Volume 54, pp. 139 - 148
Journal Article
Nature (London), ISSN 1476-4687, 08/2018, Volume 560, Issue 7718, pp. 382 - 386
Tumour cells evade immune surveillance by upregulating the surface expression of programmed death-ligand 1 (PD-L1), which interacts with programmed death-1... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Exosomes - metabolism | Tumor Escape - drug effects | Prognosis | Humans | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Case-Control Studies | Neoplasm Metastasis | Immune Tolerance - immunology | Antibodies, Monoclonal, Humanized - pharmacology | Female | Immune Tolerance - drug effects | Tumor Escape - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Melanoma - pathology | B7-H1 Antigen - immunology | Disease Progression | Antineoplastic Agents, Immunological - pharmacology | Xenograft Model Antitumor Assays | B7-H1 Antigen - metabolism | Animals | B7-H1 Antigen - blood | Antineoplastic Agents, Immunological - therapeutic use | Melanoma - immunology | Mice, Nude | CD8-Positive T-Lymphocytes - drug effects | Interferon-gamma - immunology | Melanoma - drug therapy | Cell Line, Tumor | Mice | Programmed Cell Death 1 Receptor - immunology | CD8-Positive T-Lymphocytes - immunology | Interferon-gamma - blood | Viral antibodies | Immunosuppression | Antibodies | Metastasis | Research | T cells | Properties | Biological response modifiers | Therapy | PD-1 protein | CD8 antigen | Lymphocytes T | Exosomes | Cancer therapies | Metastases | Skin cancer | Proteins | Vesicles | Lymphocytes | Immunotherapy | Immune system | Immunoglobulins | Melanoma | Immunosurveillance | T cell receptors | Patients | Immune checkpoint | Microscopy | PD-L1 protein | Ligands | Interferon | Head & neck cancer | Tumors | Apoptosis | Index Medicus
Journal Article
Journal Article